Passive Dietary Intake Assessment Study
Launched by IMPERIAL COLLEGE LONDON · Oct 26, 2018
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
The Passive Dietary Intake Assessment Study is focused on finding a better way to measure what people eat. Currently, many methods used to track dietary intake can be quite inaccurate, leading to a gap in understanding nutritional health, especially in low and middle-income countries where malnutrition is a significant concern. This study aims to create a low-cost and effective system that can automatically recognize food, record what is eaten, and estimate the nutrients in those foods. The system will be tested in real-world settings in Ghana and Kenya to ensure it works well.
To participate in this study, households must include both parents and at least one child under five years old or an adolescent. All family members should eat the same prepared meal, and participants need to be comfortable using a camera or video recording device to capture their food preparation and eating habits. If selected, participants can expect to help develop a tool that could improve our understanding of dietary habits and aid in addressing malnutrition in their communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Household comprising of both parents (mother and father) and at least a child/children under 5 years of age and/or an adolescent child
- • 2. Members of the household eat the same prepared meal
- • 3. Willingness to use a camera/video recording device to capture household food preparation and consumption.
- Exclusion Criteria:
- • Households not meeting the above inclusion criteria will not be recruited
About Imperial College London
Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Gary Frost, PhD
Principal Investigator
Imperial College London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials